Literature DB >> 6830335

Discontinuous or "skip" metastases in breast carcinoma. Analysis of 1228 axillary dissections.

P P Rosen, M L Lesser, D W Kinne, E J Beattie.   

Abstract

Patterns of axillary lymph node metastases were analyzed in 1228 recently performed modified, radical, and extended radical mastectomies. In these specimens the position or level of lymph nodes was designated intraoperatively by the surgeon. No lymph node metastases were found in 720 (58) of the specimens while the remainder (508 or 41%) had at least one affected lymph node. The distribution of involvement by level showed progressive spread from level I to III as the number of positive lymph nodes increased. Discontinuous or "skip" metastases not following this pattern occurred in 1.6% of all cases and 3% of those with lymph node metastases (95% confidence interval, 1-5%). Half of those with "skip" metastases had tumor limited to level II. The presence of "skip" metastases was not related to the size, location in the breast, or histologic type of the primary tumor. It is apparent that the potential risk from "skip" metastases is not great and that this should not be a major consideration in therapeutic decisions. The risk is likely to be negligible for women treated by axillary dissections that include level II.

Entities:  

Mesh:

Year:  1983        PMID: 6830335      PMCID: PMC1352730          DOI: 10.1097/00000658-198303000-00006

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  17 in total

1.  Curability of patients with invasive breast carcinoma based on a 30-year study.

Authors:  G F Robbins; J Berg
Journal:  World J Surg       Date:  1977-05       Impact factor: 3.352

2.  Simple mastectomy and pectoral node biopsy.

Authors:  A P Forrest; M M Roberts; E Cant; A Shivas
Journal:  Br J Surg       Date:  1976-08       Impact factor: 6.939

3.  Cancer of the breast: size of neoplasm and prognosis.

Authors:  B Fisher; N H Slack; I D Bross
Journal:  Cancer       Date:  1969-11       Impact factor: 6.860

4.  Number of lymph nodes examined and the prognosis of breast carcinoma.

Authors:  B Fisher; N H Slack
Journal:  Surg Gynecol Obstet       Date:  1970-07

5.  Carcinoma of the breast: analysis of total lymph node involvement versus level of metastasis.

Authors:  J A Smith; J J Gamez-Araujo; H S Gallager; E C White; C M McBride
Journal:  Cancer       Date:  1977-02       Impact factor: 6.860

6.  An improved technique for the study of lymph nodes in surgical specimens.

Authors:  K Durkin; C D Haagensen
Journal:  Ann Surg       Date:  1980-04       Impact factor: 12.969

7.  Assessment of axillary lymph node status.

Authors:  G C Davies; R R Millis; J L Hayward
Journal:  Ann Surg       Date:  1980-08       Impact factor: 12.969

8.  The pathological classification of human mammary carcinoma: past, present and future.

Authors:  P P Rosen
Journal:  Ann Clin Lab Sci       Date:  1979 Mar-Apr       Impact factor: 1.256

9.  Radiation therapy of early carcinoma of the breast without mastectomy.

Authors:  S Hellman; J R Harris; M B Levene
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

10.  Axillary lymph node metastases in patients with occult noninvasive breast carcinoma.

Authors:  P P Rosen
Journal:  Cancer       Date:  1980-09-01       Impact factor: 6.860

View more
  27 in total

1.  [Sentinel lymph node biopsy in breast cancer].

Authors:  A Rody; C Solbach; M Kaufmann
Journal:  Chirurg       Date:  2004-08       Impact factor: 0.955

2.  Radical axillary dissection in the staging and treatment of breast cancer.

Authors:  A B Ball; R Waters; S Fish; J M Thomas
Journal:  Ann R Coll Surg Engl       Date:  1992-03       Impact factor: 1.891

3.  Complications of level I and II axillary dissection in the treatment of carcinoma of the breast.

Authors:  D F Roses; A D Brooks; M N Harris; R L Shapiro; J Mitnick
Journal:  Ann Surg       Date:  1999-08       Impact factor: 12.969

4.  Intraoperative assessment of axillary lymph node metastases in operable breast cancer.

Authors:  M Noguchi; M Minami; M Earashi; T Taniya; I Miyazaki; Y Mizukami; A Nonomura
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry.

Authors:  C I Utech; C S Young; P F Winter
Journal:  Eur J Nucl Med       Date:  1996-12

6.  Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging.

Authors:  Till-Alexander Heusner; Sherko Kuemmel; Angela Koeninger; Monia E Hamami; Steffen Hahn; Anton Quinsten; Andreas Bockisch; Michael Forsting; Thomas Lauenstein; Gerald Antoch; Alexander Stahl
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-04       Impact factor: 9.236

7.  Melanoma with unknown primary: report and analysis of 24 patients.

Authors:  Rita Clerico; Ugo Bottoni; Giovanni Paolino; Marina Ambrifi; Paola Corsetti; Valeria Devirgiliis; Stefano Calvieri
Journal:  Med Oncol       Date:  2012-03-30       Impact factor: 3.064

8.  Validity of modified gastrectomy combined with sentinel node navigation surgery for early gastric cancer.

Authors:  Hironori Ohdaira; Hiroshi Nimura; Norio Mitsumori; Naoto Takahashi; Hideyuki Kashiwagi; Katsuhiko Yanaga
Journal:  Gastric Cancer       Date:  2007-06-25       Impact factor: 7.370

9.  Lymphatic mapping and sentinel lymphadenectomy for breast cancer.

Authors:  A E Giuliano; D M Kirgan; J M Guenther; D L Morton
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

10.  Breast carcinoma in women 35 years of age or younger.

Authors:  P P Rosen; M L Lesser; D W Kinne; E J Beattie
Journal:  Ann Surg       Date:  1984-02       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.